Biosynthesis of Antibacterial Iron-Chelating Tropolones in Aspergillus nidulans as Response to Glycopeptide-Producing Streptomycetes
- verfasst von
- Jennifer Gerke, Anna M. Köhler, Jan Peer Wennrich, Verena Große, Lulu Shao, Antje K. Heinrich, Helge B. Bode, Wanping Chen, Frank Surup, Gerhard H. Braus
- Abstract
The soil microbiome comprises numerous filamentous fungi and bacteria that mutually react and challenge each other by the production of bioactive secondary metabolites. Herein, we show in liquid co-cultures that the presence of filamentous Streptomycetes producing antifungal glycopeptide antibiotics induces the production of the antibacterial and iron-chelating tropolones anhydrosepedonin (1) and antibiotic C (2) in the mold Aspergillus nidulans. Additionally, the biosynthesis of the related polyketide tripyrnidone (5) was induced, whose novel tricyclic scaffold we elucidated by NMR and HRESIMS data. The corresponding biosynthetic polyketide synthase-encoding gene cluster responsible for the production of these compounds was identified. The tropolones as well as tripyrnidone (5) are produced by genes that belong to the broad reservoir of the fungal genome for the synthesis of different secondary metabolites, which are usually silenced under standard laboratory conditions. These molecules might be part of the bacterium-fungus competition in the complex soil environment, with the bacterial glycopeptide antibiotic as specific environmental trigger for fungal induction of this cluster.
- Externe Organisation(en)
-
Georg-August-Universität Göttingen
Helmholtz-Zentrum für Infektionsforschung GmbH (HZI)
Goethe-Universität Frankfurt am Main
Max-Planck-Institut für terrestrische Mikrobiologie
- Typ
- Artikel
- Journal
- Frontiers in Fungal Biology
- Band
- 2
- ISSN
- 2673-6128
- Publikationsdatum
- 03.01.2022
- Publikationsstatus
- Veröffentlicht
- Peer-reviewed
- Ja
- ASJC Scopus Sachgebiete
- Umweltwissenschaften (sonstige), Mikrobiologie, Ökologie, Evolution, Verhaltenswissenschaften und Systematik, Infektionskrankheiten
- Ziele für nachhaltige Entwicklung
- SDG 3 – Gute Gesundheit und Wohlergehen
- Elektronische Version(en)
-
https://doi.org/10.3389/ffunb.2021.777474 (Zugang:
Offen)